View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Theme
  2. Macro
  3. Covid-19
June 24, 2020

North China: Easing of Covid-19 lockdown represents investment opportunities for international companies

By Victoria Smith

The Northern Chinese province of Hebei, a leading region for pharmaceutical production, will offer excellent potential for pharma investment as it exits Covid-19 lockdown.

Hebei has always been among the top Chinese provinces for pharmaceutical manufacturing and, although in recent months production has been affected by the coronavirus, it contributes strong acquisition potential due to a substantial number of small companies operating in the area with a single facility. Read more here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology